FP14.07 Combination Osimertinib plus Selpercatinib for EGFR-mutant Non-Small Cell Lung Cancer (NSCLC) with Acquired RET fusions
暂无分享,去创建一个
A. Drilon | M. Scheffler | J. Goldman | G. Oxnard | J. Patel | M. Awad | Helena A. Yu | J. Rotow | A. Santucci | S. Clifford | J. Kherani | M. Hanley | H. Nechustan | R. Tupper | L. Silva | H. Yu